Full-text search

Results for “Cowen and Company, LLC”

Search across the indexed text of every released document.

25,630 documents found

COLLABORATIVE INSIGHTS February 25, 2019
document IMAGES-008-HOUSE_OVERSIGHT_024893.txt Feb 25, 2019 House Oversight Committee — Epstein Estate Records (Nov 2025)

COWEN COLLABORATIVE INSIGHTS February 25, 2019 Maine 2 Despite being one of 10 states to legalize marijuana for recreational use, health officials in Maine recently ordered businesses in the state to remove CBD-infused edibles from store shelves according to an article in the...

COLLABORATIVE INSIGHTS February 25, 2019
document IMAGES-008-HOUSE_OVERSIGHT_024909.txt Feb 25, 2019 House Oversight Committee — Epstein Estate Records (Nov 2025)

COWEN COLLABORATIVE INSIGHTS February 25, 2019 GW’s platform allows it to produce chemotypes with precise concentrations of various cannabinoids, and the company is testing numerous other cannabinoids. GW’s CBDV drug is in a 10 patient investigator sponsored trial in autism spec...

On 22-23 June 2018, the Chinese Communist Party concluded its Central Conference on Work
document TEXT-001-HOUSE_OVERSIGHT_026856.txt Jun 23, 2018 House Oversight Committee — Epstein Estate Records (Nov 2025)

XI JINPING, CHINA AND THE GLOBAL ORDER: THE SIGNIFICANCE OF CHINA’S 2018 CENTRAL FOREIGN POLICY WORK CONFERENCE THE HON. KEVIN RUDD 26 TH PRIME MINISTER OF AUSTRALIA PRESIDENT OF THE ASIA SOCIETY POLICY INSTITUTE, NEW YORK AN ADDRESS TO THE LEE KUAN YEW SCHOOL OF PUBLIC POLICY N...

Fwd: Larry Summers - Foreign Affairs - The Fusion of Civilizations
email TEXT-001-HOUSE_OVERSIGHT_026840.txt May 4, 2016 House Oversight Committee — Epstein Estate Records (Nov 2025)

From: Lesley Groff Sent: 5/4/2016 6:06:21 PM To: Jefffrey Epstein [[email protected]] Subject: Fwd: Larry Summers - Foreign Affairs - The Fusion of Civilizations Importance: High Begin forwarded message: From: Kelly Friendly Subject: Larry Summers - Foreign Affairs - The Fusi...

Part 2: Filer's Employment Assets and Income
document IMAGES-004-HOUSE_OVERSIGHT_016709.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

Filer’s Name a Donald J. Trump Part 2: Filer's Employment Assets and Income |Description EIF |attached schedule Income Amount | (Part 2 - BIT A) ; Reference # TRUMP TOWER MANAGING MEMBER INC. WA 1445 $1,001 - $15,000 None (or less than $201) Value reported reflects bank accoun...

Web Joint ¢.4webdjoint
document IMAGES-008-HOUSE_OVERSIGHT_024799.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

ACKRELL CAPITAL Web Joint ¢.4webdjoint Los Angeles, California www.webjoint.com Web Joint is an online technology software- as-a-service company. The company provides software for dispensaries to manage point-of- sale transactions, online ordering and delivery management. The s...

Trinidad, California
document IMAGES-008-HOUSE_OVERSIGHT_024787.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

ACKRELL CAPITAL Humboldt Humboldt Legends Legends Trinidad, California www.humboldtlegends.com Humboldt Legends is a producer of canna- bis flower products sourced from Humboldt County, California. The company offers can- nabis flower in eighths and pre-rolls. The com- pany’s...

Report on Stem Cells future
email TEXT-001-HOUSE_OVERSIGHT_013482.txt Nov 22, 2012 House Oversight Committee — Epstein Estate Records (Nov 2025)

From: Steven Victor MD 111.11111..... Sent: 11/23/2012 1:06:38 PM To: CC: Subject: Report on Stem Cells future PUBLISHED: 22 NOVEMBER 2012 The view from the US: Stem cell therapy steps up a gear with first approval and improved political climate Special Report Peter Winter Positi...

European Landscape
document IMAGES-008-HOUSE_OVERSIGHT_024896.txt Feb 25, 2019 House Oversight Committee — Epstein Estate Records (Nov 2025)

COWEN COLLABORATIVE INSIGHTS 80 February 25, 2019 European Landscape European Parliament Resolution In February 2019, the European Parliament passed a significant resolution to create harmonized policies and standardized practices for medical cannabis products in the EV. The...

Filer's Name Page Number
document IMAGES-001-HOUSE_OVERSIGHT_010639.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

Filer's Name Page Number Donald J. Trump 23 of 51 Part 2: Filer's Employment Assets and Income Description attached schedule Value Income Type Income Amount (Part 2 - EXHIBIT A) Reference # TRUMP VIRGINIA LOT 5 LLC $500,001 - $1,000,000 $50,001 - $100,000 Underlying Assets: vin...

UMB Financial Corp, Wells Fargo, Zions
document IMAGES-002-HOUSE_OVERSIGHT_014394.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

UMB Financial Corp, Wells Fargo, Zions. BofA Merrill Lynch Research Personnel (including the analyst(s) responsible for this report) receive compensation based upon, among other factors, the overall profitability of Bank of America Corporation, including profits derived from inv...

Morgan Stanley | sesearcs NORTH AMERICA INSIGHT ~~
document IMAGES-008-HOUSE_OVERSIGHT_025586.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

Morgan Stanley | sesearcs NORTH AMERICA INSIGHT ~~ known to, professionals in other Morgan Stanley business areas, including investment banking personnel. Morgan Stanley Research personnel may participate in company events such as site visits and are generally prohibited from a...

companies should be aware of the risks involved in engag
document IMAGES-007-HOUSE_OVERSIGHT_022524.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

companies should be aware of the risks involved in engag- ing third-party agents or intermediaries. The fact that a bribe is paid by a third party does not eliminate the poten- tial for criminal or civil FCPA liability.?! For instance, a four-company joint venture used two agent...

There may be significant delays in obtaining reimbursement for newly approved drugs, and
document IMAGES-007-HOUSE_OVERSIGHT_024071.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

There may be significant delays in obtaining reimbursement for newly approved drugs, and coverage may be more limited than the purposes for which the drug is approved by the FDA or similar regulatory authorities outside the United States. Moreover, eligibility for reimbursement d...